13F-HR filed by Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 41 holding rows worth $145,587,000.
- Accession
- 0001012975-22-000350
- Filer
- CIK 1782539
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A combination report, 40 entries on the cover page, a total value of $145,587,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $145,587,000 with VALUE read as thousands by filing date, 13F file number 028-21371. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerPivotal bioVenture Partners Investment Advisor LLC028-20630
- reports for this filerPivotal bioVenture Partners Fund I U.G.P., Ltd028-20631
- included managerPivotal bioVenture Partners Investment Advisor LLC028-20630
- included managerPivotal bioVenture Partners Fund I U.G.P., Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 635,978 | $31,017,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 225,688 | $28,552,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 119,196 | $21,975,000 | thousands by filing date | |
| EXSCIENTIA PLC | 30223G102 | ADS | 770,200 | $8,387,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 47,096 | $8,333,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 1,696,558 | $7,668,000 | thousands by filing date | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 493,584 | $5,099,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 114,380 | $3,479,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 155,199 | $2,713,000 | thousands by filing date | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 19,210 | $2,671,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 34,391 | $2,613,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 1,166,952 | $2,381,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 237,484 | $2,285,000 | thousands by filing date | |
| EARGO INC | 270087109 | COM | 2,886,724 | $2,171,000 | thousands by filing date | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 173,582 | $2,114,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 12,022 | $1,946,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 851,080 | $1,770,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 64,200 | $1,337,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 370,950 | $946,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 35,830 | $888,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 613,223 | $797,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 78,720 | $775,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 144,840 | $640,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 142,900 | $592,000 | thousands by filing date | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 40,273 | $532,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 6,115 | $507,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 29,984 | $422,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,110 | $421,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,168 | $387,000 | thousands by filing date | |
| HASHICORP INC | 418100103 | COM CL A | 13,001 | $383,000 | thousands by filing date | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 41,950 | $339,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 3,917 | $294,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 8,265 | $251,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 81,172 | $225,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 14,756 | $156,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 19,622 | $150,000 | thousands by filing date | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 12,521 | $133,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 68,634 | $79,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 14,172 | $75,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 19,335 | $56,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 11,337 | $28,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-22-000350 | this filing | 2022-08-12 | acceptance time not in the bulk data set |